(Q56994227)
English
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides
article by Antonio Curti et al published November 2007 in British Journal of Haematology
Statements
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides (English)
0 references
November 2007
0 references
139
0 references
3
0 references
415-24
0 references
1 reference